Funding news
QunaSys logo

QunaSys Secures $11 Million in Series B Funding to Accelerate Quantum Technology Innovation in Chemistry

Recently funded · $11.1M Series bTechnology/Software Development

Get the full QunaSys company profile

Access contacts, investors, buying signals & more

Open in Dashboard

QunaSys, the world’s leading developer of advanced algorithms in the field of chemistry, has successfully raised an impressive $11,100,000 in its latest funding round. Founded in 2018, QunaSys has consistently been at the forefront of harnessing the power of quantum computing to accelerate the applicability of quantum technologies. This recent influx of capital is set to further enhance the company’s innovative endeavors, specifically in developing cutting-edge quantum chemical calculation software that operates across multiple technology platforms. With an aim to maximize quantum computing benefits in diverse chemical industries, the funding will bolster QunaSys's capabilities in refining its software offerings and expanding its collaborations within the QPARC industry consortium and with esteemed academic and governmental research institutions. The capital will also facilitate the company in scaling its operations to meet the growing demand for quantum technology integration in various sectors, paving the way for breakthroughs that could revolutionize chemical-related industries. As QunaSys continues to lead the charge in quantum technology applicability, this funding marks a significant milestone in its mission to transform and elevate the field of chemistry through revolutionary computing paradigms.

Other recently funded companies

View all

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
Garner Health logo

Garner Health

$45.0M
2
Signos logo

Signos

$20.0M
3
XCENA logo

XCENA

South Korea

$135.0M
4
Photonic Inc. logo

Photonic Inc.

Canada

$70.0M
5
Slamcore logo

Slamcore

United Kingdom

$13.0M